| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 58 |
| 1 | ISOTRETINOIN | 9 |
| 2 | TOLVAPTAN | 7 |
| 3 | PEXIDARTINIB HYDROCHLORIDE | 4 |
| 4 | VEDOLIZUMAB | 4 |
| 5 | ASPIRIN | 3 |
| 6 | ASPIRIN 325 MG | 3 |
| 7 | ASPIRIN 81 MG | 3 |
| 8 | DEXAMETHASONE | 3 |
| 9 | FUROSEMIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEXIDARTINIB HYDROCHLORIDE | 4 | 0.0056 |
| 1 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 2 | HALOPERIDOL DECANOATE | 1 | 0.0006 |
| 3 | FLUOCINOLONE ACETONIDE | 2 | 0.0005 |
| 4 | LOMITAPIDE MESYLATE | 2 | 0.0005 |
| 5 | TOLVAPTAN | 7 | 0.0005 |
| 6 | CLOZAPINE | 58 | 0.0005 |
| 7 | PILOCARPINE HYDROCHLORIDE | 1 | 0.0004 |
| 8 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 | 0.0003 |
| 9 | IDURSULFASE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 59 |
| 1 | Retinoid [EPC] | 9 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 7 |
| 3 | Corticosteroid [EPC] | 5 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 5 | Integrin Receptor Antagonist [EPC] | 4 |
| 6 | Benzodiazepine [EPC] | 3 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 3 |
| 8 | Insulin Analog [EPC] | 3 |
| 9 | Loop Diuretic [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin V2 Receptor Antagonist [EPC] | 7 | 0.0005 |
| 1 | Atypical Antipsychotic [EPC] | 59 | 0.0001 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 5 | Integrin Receptor Antagonist [EPC] | 4 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 8 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 9 | Retinoid [EPC] | 9 | 0.0000 |